{"transactions":[{"id":4639270,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-10-13T20:05:08.000Z","date":"2026-10-12","kind":"grant","planned":false,"acquired":true,"shares":3946,"price":5.53,"value":21821.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Issuer's common shares were acquired pursuant to the Fennec Pharmaceuticals Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of April 9, 2026 through October 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on the Nasdaq Capital Market on April 9, 2026."}],"balance_after":28746,"source":{"system":"sec-edgar","filing":"0002043411-26-000018","document":"form4-10132026_041003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000018/form4-10132026_041003.xml","form_type":"4"}},{"id":4634147,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-10-02T00:05:07.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24800,"source":{"system":"sec-edgar","filing":"0002043411-26-000016","document":"form4-10012026_041003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000016/form4-10012026_041003.xml","form_type":"4"}},{"id":672178,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-09-01T00:12:29.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24644,"source":{"system":"sec-edgar","filing":"0002043411-26-000014","document":"form4-09012026_120925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000014/form4-09012026_120925.xml","form_type":"4"}},{"id":699080,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-08-03T20:05:13.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24488,"source":{"system":"sec-edgar","filing":"0002043411-26-000012","document":"form4-08032026_040808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000012/form4-08032026_040808.xml","form_type":"4"}},{"id":721592,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-07-01T20:34:01.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24332,"source":{"system":"sec-edgar","filing":"0002043411-26-000010","document":"form4-07012026_080757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000010/form4-07012026_080757.xml","form_type":"4"}},{"id":757395,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-06-01T20:05:19.000Z","date":"2026-05-31","kind":"grant","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24176,"source":{"system":"sec-edgar","filing":"0002043411-26-000008","document":"form4-06012026_040609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000008/form4-06012026_040609.xml","form_type":"4"}},{"id":795926,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-05-01T20:05:18.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":24020,"source":{"system":"sec-edgar","filing":"0002043411-26-000006","document":"form4-05012026_040505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000006/form4-05012026_040505.xml","form_type":"4"}},{"id":820358,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Options","published_at":"2026-04-02T20:05:27.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":5.77,"value":692400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to this option may be exercised as of March 31, 2027 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested."}],"balance_after":265300,"derivative":{"exercise_price":5.77,"exercise_date":"2027-03-31","expiration_date":"2036-03-31","underlying":"Common Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0002043411-26-000004","document":"form4-04022026_040407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000004/form4-04022026_040407.xml","form_type":"4"}},{"id":820357,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-04-02T20:05:27.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":true,"shares":1901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":23865,"source":{"system":"sec-edgar","filing":"0002043411-26-000004","document":"form4-04022026_040407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000004/form4-04022026_040407.xml","form_type":"4"}},{"id":820356,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-04-02T20:05:27.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares released from restriction from shares awarded 3/28/2025."}],"balance_after":21964,"source":{"system":"sec-edgar","filing":"0002043411-26-000004","document":"form4-04022026_040407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000004/form4-04022026_040407.xml","form_type":"4"}},{"id":820355,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-04-02T20:05:27.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":17106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents settlement of PSUs that vested on March 31, 2026."}],"balance_after":21806,"source":{"system":"sec-edgar","filing":"0002043411-26-000004","document":"form4-04022026_040407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000004/form4-04022026_040407.xml","form_type":"4"}},{"id":827507,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Options","published_at":"2026-03-26T20:29:07.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":4700,"price":4.23,"value":19881.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $4.23 and an expiration date of November 13, 2034."}],"balance_after":145300,"derivative":{"exercise_price":4.23,"exercise_date":"2025-11-13","expiration_date":"2034-11-13","underlying":"Common Shares","underlying_shares":4700},"source":{"system":"sec-edgar","filing":"0002043411-26-000002","document":"form4-03262026_080303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000002/form4-03262026_080303.xml","form_type":"4"}},{"id":827506,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common shares","published_at":"2026-03-26T20:29:07.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":true,"shares":4700,"price":4.23,"value":19881.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares acquired through the exercise of an option contract with strike price of $4.23 and an expiration date of November 13, 2034."}],"balance_after":4700,"source":{"system":"sec-edgar","filing":"0002043411-26-000002","document":"form4-03262026_080303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000204341126000002/form4-03262026_080303.xml","form_type":"4"}},{"id":1180355,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Restricted Share Unit","published_at":"2025-04-03T23:16:28.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 28, 2025, Christiana Cioffi was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the \"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction."}],"balance_after":160000,"derivative":{"exercise_price":0,"exercise_date":"2026-03-28","expiration_date":"2035-03-28","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-010071","document":"form4a-04032025_110424.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000141588925010071/form4a-04032025_110424.xml","form_type":"4/A","original_submission_date":"2025-04-03"}},{"id":1180353,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Restricted Share Unit","published_at":"2025-04-03T22:10:51.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 28, 2025, Christiana Cioffi was awarded restricted share units to acquire 10,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the \"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction."}],"balance_after":10000,"derivative":{"exercise_price":0,"exercise_date":"2026-03-28","expiration_date":"2035-03-28","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-25-010053","document":"form4-04032025_100448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000141588925010053/form4-04032025_100448.xml","form_type":"4"}},{"id":1366923,"issuer":{"id":5601,"kind":"organization","name":"FENNEC PHARMACEUTICALS INC.","symbol":"FENC"},"owners":[{"id":18461,"kind":"person","name":"Cioffi Christiana Marie","position":1,"cik":"0002043411","reported_name":"Cioffi Christiana Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Stock Options","published_at":"2024-11-13T22:15:08.000Z","date":"2024-11-13","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":4.23,"value":634500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 13, 2024,Christiana Cioffi was granted incentive stock options to purchase 150,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to this option may be exercised as of November 13, 2025 (\"Vesting Commencement Date\"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date until all shares have vested."}],"balance_after":150000,"derivative":{"exercise_price":4.23,"exercise_date":"2025-11-13","expiration_date":"2034-11-13","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-24-026727","document":"form4-11132024_101104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043411/000141588924026727/form4-11132024_101104.xml","form_type":"4"}}]}